Objective: Well-controlled glucose levels (ie, 70-180 mg/dL) have been associated with lower mortality from COVID-19. The addition of dexamethasone to COVID-19 treatment protocols has raised concerns about the potential negative consequences of dexamethasone-induced hyperglycemia.
Methods: We developed a protocol to guide the management of dexamethasone-induced hyperglycemia in hospitalized patients with COVID-19.
Obes Res Clin Pract
September 2021
We report a case of a 36 year old gentleman presenting with polyneuropathy and Korsakkoff Syndrome complicating Sleeve Gastrectomy.
View Article and Find Full Text PDF